Purified anti-MAVS Antibody, MAVS, W21144C,BioLegend,624351

The clone does not cross-react with mouse in western blotting (WB).For immunocytochemistry (ICC), we recommend to use 4% PFA fixation followed by permeabilization with 0.5% Triton X-100 or ice cold-methanol, or ice-cold methanol fixation.For immunohistochemistry (IHC-P), antigen retrieval with Citrate Buffer (Cat. No. 420901) or Tris-EDTA pH 9.0 is recommended.

Host

Rat

Reactivity

Human

Application

WB - Quality testedICC, IHC-P - Verified

Platform ID

BAB461412882

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-MAVS Antibody, MAVS, W21144C
Cat. No.624351
HostRat
RRIDAB_3097498 (BioLegend Cat. No. 624351)AB_3097498 (BioLegend Cat. No. 624352)
IsotypeRat IgG2b, κ
ReactivityHuman
ApplicationWB - Quality testedICC, IHC-P - Verified
ClonalityMonoclonal
Clone NumberW21144C
Concentration0.5 mg/mL
TargetMAVS
ImmunogenPartial Recombinant human MAVS protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Mitochondrial antiviral signaling protein (MAVS) is essential and specific for innate immunity by activating IRF3, IRF7 and NF-κB in response to viral infection. MAVS is located on the outer membranes of mitochondria, peroxisomes, and mitochondria-associated endoplasmic reticulum membranes (MAM). The MAVS protein contains an N-terminal CARD domain and a C-terminal mitochondrial transmembrane domain. MAVS acts downstream of the RIG-I RNA helicase and sensing viral RNA, leading to the recruitment of IKKε, TRIF and TRAF6. Some viruses have developed strategies to evade these innate defense mechanisms by using proteases that cleave MAVS and prevent its localization to mitochondria. The C-terminal region of MAVS cleavage by the hepatitis C virus (HCV) protease allows HCV to evade the host immune system.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.